The Study is Coming from Inside the Drug Company: Some Doctors Fail to Disclose Conflicts of Interest

December 12, 2018 | Strategic Insights for Health System

Preview

​Many doctors fail to disclose financial relationships with pharmaceutical and health companies when publishing their research in medical journals, according to a December 8, 2018, report from ProPublicaand the New York Times. In one such example, a prominent physician declared in the New England Journal of Medicine and Journal of Clinical Oncology that he had no conflicts of interest, at the same time that drug companies paid his employer $114,000 for consulting and speaking fees as well as $8 million for research. The journals themselves do not routinely vet disclosures even when the information could be easily discovered, the authors said.

Access Full Content

Contact us today at 610.825.6000.